Back

Characterising patients and lesions with plaque progression despite high-intensity LDL-C-lowering therapy: a multimodality serial intracoronary imaging study from the IBIS-4 and PACMAN-AMI trials

28 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Multimodality cardiac computed tomography and cardiovascular magnetic resonance in pericardial and myocardial disease Imaging of Coronary Artery Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Ryota Kakizaki

Kitasato University School of Medicine, Sagamihara (Japan)

6 More presentations in this session

Presentation thumbnail
Multimodality pericardial phenotype on CT and CMR predicts treatment failure in inflammatory and constrictive pericardial syndromes
Doctor A. Tawfek (Cardiff, GB)
Presentation thumbnail
Prognostic value of quantitative SPECT/CT metrics in transthyretin amyloid cardiomyopathy
Doctor G. Tersalvi (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Diagnostic utility of spectral computed tomography in acute myocardial damage without obstructive coronary disease: the CADAMI-SPECTRAL study
Doctor C. Herrera (Salamanca, ES)
Abstract Slides Video
Presentation thumbnail
Border zone channel mass predicts ventricular arrhythmias independently of LVEF in ICD patients
Doctor J. Lubian Esplugues (Cadiz, ES)
Abstract Slides Video
Presentation thumbnail
Differential effects of Tafamidis on cardiac remodelling in transthyretin amyloid cardiomyopathy: evidence from contemporary imaging data
Doctor A. Jirjis (Sydney, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Multimodality cardiac computed tomography and cardiovascular magnetic resonance in pericardial and myocardial disease

The Event

Event poster

ESC Congress 2026

28 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Interrelation between baseline plaque characteristics and changes in coronary atherosclerosis with the PCSK9-inhibitor alirocumab: Insights from the PACMAN-AMI randomized trial
26 August 2022
thumbnail
Congress Presentation
Intensified hypolipidaemic therapy with inclisiran for atherosclerotic plaque stabilization
30 August 2025
thumbnail
Congress Presentation
Direct versus late maxLCBI4mm changes after paclitaxel-coated balloon treatment of lipid-rich plaques
31 August 2025
thumbnail
Congress Presentation
Association between CCTA-identified high-risk plaques and preventive therapy modification
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources